Valeant Pharmaceuticals (VRX) Announces $1.5B Securites Repurchase Program
Tweet Send to a FriendGet Alerts VRX Hot Sheet
Up)
Trade VRX Now!
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced an $1.5 billion securities repurchase program.
Under the Securities Repurchase Program, which commenced November 15, 2012, the Company may make purchases of up to $1.5 billion of its senior notes, common shares and/or other debt or shares that may be issued prior to the completion of the program. The Securities Repurchase Program will replace the Company's former securities repurchase program, which expired on November 7, 2012.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Under the Securities Repurchase Program, which commenced November 15, 2012, the Company may make purchases of up to $1.5 billion of its senior notes, common shares and/or other debt or shares that may be issued prior to the completion of the program. The Securities Repurchase Program will replace the Company's former securities repurchase program, which expired on November 7, 2012.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of Directors
- Melco Crown (MPEL) Approves ADS Purchase Program
- Northrop Grumman (NOC) Adds $4B to Repurchase Plan, Plans to Retire 25% Outstanding Shares
Create E-mail Alert Related Categories
Stock Buybacks
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
